Warby Parker Inc. reported $912M of revenue over the trailing twelve months, +11% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $912M (to Q2 2026). Net income: $7.7M, trailing twelve months to Q2 2026. Free cash flow: $22M, trailing twelve months to Q2 2026. Operating margin: 0.10%, trailing twelve months to Q2 2026.

WRBYWarby Parker Inc.

Healthcare

$25.30-11% 1Y

$25.30

$16.4952 weeks$30.23

Latest close: back above its 200-day averageOct 9, 2026what changed →

WRBY as reported

Warby Parker Inc. reported $912M of revenue over the trailing twelve months, +11% on the year before. 9 reported series are charted on this page, each one as filed.

$912M

Revenue, trailing twelve months · to Q2 2026 · +11% against the twelve months before

Net income: $7.7M
Net income · −184% year on year · trailing twelve months to Q2 2026
Free cash flow: $22M
Free cash flow · −58% year on year · trailing twelve months to Q2 2026
Operating margin: 0.10%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for WRBY, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$912M	+11%	Q2 2026
Net income	$7.7M	−184%	Q2 2026
EPS	$0.07	−200%	Q2 2026
Gross margin	55%	n/a	Q2 2026
Operating margin	0.10%	n/a	Q2 2026
Net margin	0.78%	n/a	Q2 2026
ROE	0.74%	n/a	Q2 2026
ROA	0.38%	n/a	Q2 2026
Free cash flow	$22M	−58%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.